MedPath

哈药集团中药二厂

Ownership
-
Established
2021-09-09
Employees
-
Market Cap
-
Website
www.zy2c.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

111

NMPA:111

Drug Approvals

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20253805
Approval Date
Apr 1, 2025
NMPA

妇科调经片

Approval Number
国药准字Z20093652
Approval Date
May 5, 2022
NMPA

大山楂丸

Approval Number
国药准字Z23021828
Approval Date
Dec 7, 2020
NMPA

西羚丸

Approval Number
国药准字Z23021420
Approval Date
Dec 7, 2020
NMPA

九味羌活丸

Approval Number
国药准字Z23021831
Approval Date
Dec 7, 2020
NMPA

黄连上清丸

Approval Number
国药准字Z23022042
Approval Date
Dec 7, 2020
NMPA

小儿至宝丸

Approval Number
国药准字Z23021216
Approval Date
Dec 7, 2020
NMPA

熊胆救心丸

Approval Number
国药准字Z23021757
Approval Date
Dec 7, 2020
NMPA

橘红丸

Approval Number
国药准字Z23021218
Approval Date
Dec 7, 2020
NMPA

十全大补丸

Approval Number
国药准字Z23021834
Approval Date
Dec 7, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.